Literature DB >> 14725610

Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients.

Kari Raaska1, Virpi Raitasuo, Jouko Laitila, Pertti J Neuvonen.   

Abstract

Clozapine and caffeine are metabolised mainly by the cytochrome P4501A2 (CYP1A2) enzyme. Studies suggest that caffeine in coffee inhibits clozapine metabolism and increases serum clozapine concentrations. Our objective was to study whether coffee in the amounts usually consumed has an effect on steady-state serum clozapine concentrations. A randomised placebo-controlled cross-over design with two phases was used. Twelve hospitalised clozapine-using patients volunteered in the study where, after one-week run-in period, either caffeine-containing or decaffeinated instant coffee was available ad libitum for seven days. Serum concentrations of clozapine, N-desmethylclozapine, clozapine-N-oxide, caffeine, paraxanthine and C-reactive protein were measured after run-in period and on days 4 and 8 of the following study phases. Two patients were excluded from the statistical analysis because of non-compliance based on serum caffeine and paraxanthine determinations. In six fully compliant patients caffeine-containing coffee increased the mean serum trough concentration of clozapine by 26% (non-significant (NS), 95% CI -3% to +54%, P=0.07), N-desmethylclozapine by 6% (95% CI 1% to 12%, P=0.03), and clozapine-N-oxide by 7% (NS, 95% CI -6% to +20%, P=0.22). The ratio of N-desmethylclozapine/clozapine decreased by 13% (NS, 95% CI -1% to +27%, P=0.06) and that of clozapine-N-oxide/clozapine by 7% (NS, 95% CI -5% to +17%, P=0.19). In the analysis of combined data (including day 4 data of the four patients compliant up to that point) serum trough concentration of clozapine was 20% (95% CI 3% to 37% to P=0.03) higher, and that of N-desmethylclozapine 7% (95% CI 2% to 13%, P=0.02) higher during the caffeine phase than during the decaffeinated phase. We conclude that the effect of instant coffee drinking on serum clozapine concentrations is of minor clinical relevance in most of the patients, but some individuals may be more sensitive to this interaction due e.g. to genetic factors. The increase in serum clozapine concentration was most likely due to the inhibition of the CYP1A2 enzyme by caffeine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14725610

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  10 in total

Review 1.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  The influence of cytochrome P450 pharmacogenetics on disposition of common antidepressant and antipsychotic medications.

Authors:  Jan van der Weide; John W J Hinrichs
Journal:  Clin Biochem Rev       Date:  2006-02

3.  The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.

Authors:  Tore Haslemo; Per Haakon Eikeseth; Lars Tanum; Espen Molden; Helge Refsum
Journal:  Eur J Clin Pharmacol       Date:  2006-11-07       Impact factor: 2.953

4.  Clozapine Metabolism is Associated With Absolute Neutrophil Count in Individuals With Treatment-Resistant Schizophrenia.

Authors:  Isabella R Willcocks; Sophie E Legge; Mariana Nalmpanti; Lucy Mazzeo; Adrian King; John Jansen; Marinka Helthuis; Michael J Owen; Michael C O'Donovan; James T R Walters; Antonio F Pardiñas
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

5.  Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.

Authors:  Katalin Tóth; Gábor Csukly; Dávid Sirok; Ales Belic; Ádám Kiss; Edit Háfra; Máté Déri; Ádám Menus; István Bitter; Katalin Monostory
Journal:  Int J Neuropsychopharmacol       Date:  2017-07-01       Impact factor: 5.176

Review 6.  Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review.

Authors:  Claudia D'Alessandro; Alessia Benedetti; Antonello Di Paolo; Domenico Giannese; Adamasco Cupisti
Journal:  Nutrients       Date:  2022-01-04       Impact factor: 5.717

7.  Cigarette smoking, coffee consumption, alcohol intake, and clozapine metabolism: A Mendelian randomization study.

Authors:  Lingsi Zeng; Honggang Lv; Juan Li; Ranran Xue; Xia Liu; Cong Zhou; Hao Yu
Journal:  Front Psychiatry       Date:  2022-09-29       Impact factor: 5.435

8.  CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine.

Authors:  Merja Viikki; Olli Kampman; Niko Seppälä; Nina Mononen; Terho Lehtimäki; Esa Leinonen
Journal:  BMC Psychiatry       Date:  2014-02-20       Impact factor: 3.630

9.  Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations.

Authors:  Michaela Mayerova; Libor Ustohal; Jiri Jarkovsky; Jan Pivnicka; Tomas Kasparek; Eva Ceskova
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-14       Impact factor: 2.570

10.  Coffee Consumption and C-Reactive Protein Levels: A Systematic Review and Meta-Analysis.

Authors:  Elizabeth D Moua; Chenxiao Hu; Nicole Day; Norman G Hord; Yumie Takata
Journal:  Nutrients       Date:  2020-05-08       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.